Experimental Treatments for Leptomeningeal Metastases from Solid Malignancies-Reference-Cited by-同舟云学术

Experimental Treatments for Leptomeningeal Metastases from Solid Malignancies

Published:2017-01 Issue:1 Volume:24 Page:42-46
ISSN:1073-2748
Container-title:Cancer Control
language:en
Short-container-title:Cancer Control

Author:

Sahebjam Solmaz¹²,Forsyth Peter A.¹²³,Smalley Keiran S.⁴,Tran Nam D.¹²

Affiliation:

1. From the Departments of Neuro-Oncology, Calgary, Alberta, Canada.

2. H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, Department of Oncologic Sciences, Calgary, Alberta, Canada.

3. University of South Florida Morsani College of Medicine, Tampa, Florida, and Tom Baker Cancer Center and University of Calgary, Calgary, Alberta, Canada.

4. Tumor Biology, and Cutaneous Oncology, Calgary, Alberta, Canada.

Publisher

SAGE Publications

Subject

Oncology,Hematology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/107327481702400106

Reference38 articles.

1. Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era

2. Complete Cytologic Remission of V600E BRAF-Mutant Melanoma–Associated Leptomeningeal Carcinomatosis Upon Treatment With Dabrafenib

3. Vemurafenib for Leptomeningeal Melanomatosis

4. Long-term stabilization of leptomeningeal disease with whole-brain radiation therapy in a patient with metastatic melanoma treated with vemurafenib

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Breakthroughs in the Diagnosis of Leptomeningeal Carcinomatosis: A Review of Liquid Biopsies of Cerebrospinal Fluid;Cureus;2024-02-28

2. CSF and disease;Cerebrospinal Fluid and Subarachnoid Space;2023

3. Case Report: Focal leptomeningeal disease, atypical cancer of unknown primary site;F1000Research;2022-09-21

4. Case Report: Focal leptomeningeal disease, atypical cancer of unknown primary site in Peru;F1000Research;2022-08-02

5. Deciphering Biomarkers for Leptomeningeal Metastasis in Malignant Hemopathies (Lymphoma/Leukemia) Patients by Comprehensive Multipronged Proteomics Characterization of Cerebrospinal Fluid;Cancers;2022-01-17